Illness	Number of cases
Essential primary hypertension (I10.01)	152
Left ventricular failure unspecified (I50.13)	105
Left ventricular failure unspecified (I50.14)	98
Pneumonia organism unspecified - Bronchopneumonia unspecified organism (J18.0)	60
Viral infection of unspecified site - Coronavirus infection unspecified (B34.2)	55
Volume depletion (E86)	42
Atrial fibrillation and flutter - Paroxysmal atrial fibrillation (I48.0)	41
Viral pneumonia not elsewhere classified (J12.8)	38
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	35
Atrial fibrillation and flutter (I48.1)	34

Top 10 treatments

Treatment	Number
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	302
Computed tomography (CT) of the head without contrast medium (3-200)	291
Examination of the oesophagus, stomach and duodenum by endoscopy (1-632.0)	288
(9-984.7)	253
Computed tomography (CT) of the abdomen without contrast medium (3-207)	203
(9-984.8)	178
Computed tomography of the chest with contrast medium (3-222)	160
Taking a tissue sample (biopsy) of the upper digestive tract, biliary tract or the pancreas by endoscopy (1-440.a)	157
Treatment by specific positioning of the patient in bed, e.g. positioning in a sling table or special bed (8-390.x)	133
Computed tomography of the abdomen with contrast medium (3-225)	131

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0100

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
32	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
30	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
30	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility